Castle Biosciences (CSTL) Valuation After Upgraded 2025 Guidance And Strong Core Test Volume Growth [Yahoo! Finance]
Castle Biosciences, Inc. - Common stock (CSTL)
Last castle biosciences, inc. - common stock earnings: 3/10 04:05 pm
Check Earnings Report
Company Research
Source: Yahoo! Finance
higher test volumes for its core DecisionDx-Melanoma and TissueCypher Barrett's Esophagus franchises. See our latest analysis for Castle Biosciences. That guidance update lands after a sharp 72.47% 90 day share price return. The 1 year total shareholder return of 30.05% contrasts with a 5 year total shareholder return of a 46.94% decline, suggesting recent momentum is building from a weaker long term base. If Castle Biosciences has your attention, this is also a good time to scan other healthcare names and see how they compare using healthcare stocks With shares up sharply over 90 days, trading at US$39.34 and sitting at a modest discount to an average analyst target of US$43.75, plus a large estimated intrinsic discount, is there still a buying opportunity here, or is the market already pricing in future growth? With Castle Biosciences closing at US$39.34 against a narrative fair value of US$42.50, the story here leans toward modest undervaluation anchored in detailed forec
Show less
Read more
Impact Snapshot
Event Time:
CSTL
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CSTL alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CSTL alerts
High impacting Castle Biosciences, Inc. - Common stock news events
Weekly update
A roundup of the hottest topics
CSTL
News
- Castle Biosciences (NASDAQ:CSTL) had its "buy" rating reaffirmed by analysts at Lake Street Capital.MarketBeat
- The Bull Case For Castle Biosciences (CSTL) Could Change Following Surging Test Volumes And Raised 2025 Outlook [Yahoo! Finance]Yahoo! Finance
- Castle Biosciences Announces Preliminary Unaudited Fourth Quarter and Full–Year 2025 Results [Yahoo! Finance]Yahoo! Finance
- Castle Biosciences Announces Preliminary Unaudited Fourth Quarter and Full–Year 2025 ResultsGlobeNewswire
- Castle Biosciences (NASDAQ:CSTL) was downgraded by analysts at Zacks Research from a "strong-buy" rating to a "hold" rating.MarketBeat
CSTL
Earnings
- 11/3/25 - Beat
CSTL
Sec Filings
- 1/14/26 - Form 4
- 1/14/26 - Form 4
- 1/14/26 - Form 4
- CSTL's page on the SEC website